Delivery of small interfering RNA with a synthetic collagen poly(Pro-Hyp-Gly) for gene silencing in vitro and in vivo

Development Growth and Differentiation

Volumn 52, Issue 8, 2010, Pages 693-699

  Adachi, Taro ^a   Kawakami, Emi ^a   Ishimaru, Naozumi ^a   Ochiya, Takahiro ^b   Hayashi, Yoshio ^a   Ohuchi, Hideyo ^a   Tanihara, Masao ^c   Tanaka, Eiji ^a   Noji, Sumihare ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

delivery; myostatin; RNAi; siRNA; synthetic collagen

Indexed keywords

COLLAGEN; LUCIFERASE; MYOSTATIN; NUCLEASE; POLYMER; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE GROWTH; MUSCLE MASS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN EXPRESSION; RNA INTERFERENCE; SKELETAL MUSCLE; TUMOR XENOGRAFT;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; COLLAGEN; DNA PRIMERS; GENE SILENCING; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

ANIMALIA;

EID: 77957264207     PISSN: 00121592     EISSN: 1440169X     Source Type: Journal    
DOI: 10.1111/j.1440-169X.2010.01206.x     Document Type: Article

References (12)

1. Behlke, M. A. 2006. Progress towards in vivo use of siRNAs. Mol Ther. 13, 644 670.
2. Gary, D. J., Puri, N. Won, Y. Y. 2007. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J. Control Release 121, 64 73. (Pubitemid 47126065)
3. Kim, S-S., Garg, H., Joshi, A. Manjunath, N. 2009. Strategies for targeted nonviral delivery of siRNAs in vivo. Trends Mol. Med. 15, 491 500.
4. Kim, W. Kim, S. 2009. Efficient siRNA Delivery with Non-viral Polymeric Vehicles. Pharm. Res. 26, 657 666.
5. Kinouchi, N., Ohsawa, Y., Ishimaru, N., Ohuchi, H., Sunada, Y., Hayashi, Y., Tanimoto, Y., Moriyama, K. Noji, S. 2008. Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15, 1126 1130. (Pubitemid 352006081)
6. Kishimoto, T., Morihara, Y., Osanai, M., Ogata, S., Kamitakahara, M., Ohtsuki, C. Tanihara, M. 2005. Synthesis of poly(Pro-Hyp-Gly)(n) by direct poly-condensation of (Pro-Hyp-Gly)(n), where n = 1, 5, and 10, and stability of the triple-helical structure. Biopolymers 79, 163 172. (Pubitemid 41652912)
7. Lee, H., Sodek, K. L., Hwang, Q., Brown, T. J., Ringuette, M. Sodek, J. 2007. Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP. Biochem. Soc. Trans. 35, 704 706. (Pubitemid 47310348)
8. Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., Honma, K., Nagahara, S., Hanai, K., Sano, A., Kato, T., Terada, M. Ochiya, T. 2004. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32, e109.
9. Ochiya, T., Nagahara, S., Sano, A., Itoh, H. Terada, M. 2001. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther. 1, 31 52.
10. Stenzel, K. H., Miyata, T. Rubin, A. L. 1974. Collagen as a Biomaterial. Annu. Rev. Biophys. Bioeng. 3, 231 253.
11. Tiemann, K. Rossi, J. J. 2009. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol. Med. 1, 142 151.
12. Vooijs, M., Jonkers, J., Lyons, S. Berns, A. 2002. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res. 62, 1862 1867. (Pubitemid 34408514)